Smoking Cessation Pharmacotherapy Based on Genetically-Informed Biomarkers: What is the Evidence?

INTRODUCTION: Pharmacogenomic studies have used genetic variants to identify smokers likely to respond to pharmacological treatments for smoking cessation. METHODS: We performed a systematic review and meta-analysis of primary and secondary analyses of trials of smoking cessation pharmacotherapies....

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nicotine Tob Res
Autori principali: Panagiotou, Orestis A, Schuit, Ewoud, Munafò, Marcus R, Bennett, Derrick A, Bergen, Andrew W, David, Sean P
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2019
Soggetti:
Brief Reports
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6698953/
https://ncbi.nlm.nih.gov/pubmed/30690475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ntr/ntz009
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi